Efficacy of an ovine caseous lymphadenitis vaccine formulated using a genetically inactive form of the Corynebacterium pseudotuberculosis phospholipase D

By Hodgson A.L.M.   Carter K.   Tachedjian M.   Krywult J.   Corner L.A.   McColl M.   Cameron A.  

Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. : 802-808

Elsevier

Access to resources Recommend Favorite

Foreign gene expression in Corynebacterium pseudotuberculosis: development of a live vaccine vector

By Moore R.J.   Rothel L.   Krywult J.   Radford A.J.   Lund K.   Hodgson A.L.M.  

Vaccine, Vol. 18, Iss. 5, 1999-10 ,pp. : 487-497

Elsevier

Access to resources Recommend Favorite

Applications of glycosyltransferases in the site-specific conjugation of biomolecules and the development of a targeted drug delivery system and contrast agents for MRI

By Ramakrishnan Boopathy   Boeggeman Elizabeth   Qasba Pradman K  

Expert Opinion on Drug Delivery, Vol. 5, Iss. 2, 2008-02 ,pp. : 149-153

Informa Healthcare

Access to resources Recommend Favorite

Magnetic targeting for site-specific drug delivery: applications and clinical potential

By Polyak Boris   Friedman Gary  

Expert Opinion on Drug Delivery, Vol. 6, Iss. 1, 2009-01 ,pp. : 53-70

Informa Healthcare

Access to resources Recommend Favorite

Rapid identification of Newcastle disease virus vaccine strains LaSota and B-1 by restriction site analysis of their matrix gene

By Wehmann E.   Herczeg J.   Ballagi-Pordany A.   Lomniczi B.  

Vaccine, Vol. 15, Iss. 12, 1997-08 ,pp. : 1430-1433

Elsevier

Access to resources Recommend Favorite